Unknown

Dataset Information

0

Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study.


ABSTRACT: Treatments for childhood cancer can impair pulmonary function. We assessed the potential impact of cigarette smoking on pulmonary function in 433 adult childhood cancer survivors (CCS) who received pulmonary-toxic therapy, using single breath diffusion capacity for carbon monoxide corrected for hemoglobin (DLCOcorr), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and total lung capacity (TLC). FEV1/FVC median values among current [1.00; interquartile range (IQR): 0.94-1.04] and former smokers (0.98; IQR: 0.93-1.04) were lower than those who had never smoked (1.02; IQR: 0.96-1.06; P = 0.003). Median FEV1/FVC values were lower among those who smoked ? 6 pack-years (0.99; IQR: 0.92-1.03) and those who smoked <6 pack-years (1.00; IQR: 0.94-1.04), than among those who had never smoked (P = 0.005). Our findings suggest that CCSs have an increased risk for future obstructive and restrictive lung disease. Follow-up is needed to determine whether smoking imparts more than additive risk. Smoking prevention and cessation need to be a priority in this population.

SUBMITTER: Oancea SC 

PROVIDER: S-EPMC4167598 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study.

Oancea S Cristina SC   Gurney James G JG   Ness Kirsten K KK   Ojha Rohit P RP   Tyc Vida L VL   Klosky James L JL   Srivastava DeoKumar D   Stokes Dennis C DC   Robison Leslie L LL   Hudson Melissa M MM   Green Daniel M DM  

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20140617 9


Treatments for childhood cancer can impair pulmonary function. We assessed the potential impact of cigarette smoking on pulmonary function in 433 adult childhood cancer survivors (CCS) who received pulmonary-toxic therapy, using single breath diffusion capacity for carbon monoxide corrected for hemoglobin (DLCOcorr), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and total lung capacity (TLC). FEV1/FVC median values among current [1.00; interquartile range (IQR): 0.94-  ...[more]

Similar Datasets

| S-EPMC8633430 | biostudies-literature
| S-EPMC6344300 | biostudies-literature
| S-EPMC7302420 | biostudies-literature
| S-EPMC7552816 | biostudies-literature
| S-EPMC8059051 | biostudies-literature
| S-EPMC4165406 | biostudies-other
| S-EPMC8310532 | biostudies-literature
| S-EPMC10930858 | biostudies-literature
| S-EPMC6324960 | biostudies-literature
| S-EPMC5788007 | biostudies-literature